We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes (cirrusOCT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01067482
First Posted: February 11, 2010
Last Update Posted: March 23, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Prince of Songkla University
  Purpose
The purpose of this study is to evaluate performances of each parameters of spectral domain (Cirrus) optical coherence tomography for distinguishing between normal eyes, glaucoma suspect and glaucomatous eyes

Condition
Glaucoma Patient Glaucoma Suspect Patient Normal Population RNFL Thickness by Location Macular Thickness by Location

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: The Performances of Spectral Domain Optical Coherence Tomography for Distinguishing Between Normal Eyes, Glaucoma Suspect and Glaucomatous Eyes

Resource links provided by NLM:


Further study details as provided by Prince of Songkla University:

Estimated Enrollment: 80
Study Start Date: September 2009
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Glaucoma patients
Glaucoma suspect group
Normal population

Detailed Description:
Aim to determine which parameter of cirrus OCT is best sensitivity and specificity for glaucoma detection
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
glaucoma patient from glaucoma clinic that is POAG Glaucoma suspect cases normal population case
Criteria

Inclusion Criteria:

  • BCVA at least 20/60
  • refractive error +/- 5 D Or astig +/- 3 D
  • enrolled in 3 population group (glaucoma, glaucoma suspect or normal)

Exclusion Criteria:

  • VA less than 20/60
  • marked RF error
  • previous ocular trauma or surgery
  • unreliable visual field
  • poor signal cirrus OCT (less than 7)
  • other causes of optic nerve or macular disease other than glaucoma
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01067482


Locations
Thailand
Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University
Hat-yai,, Songkhla, Thailand., Thailand, 90110
Sponsors and Collaborators
Prince of Songkla University
Investigators
Principal Investigator: Weerawat Kiddee, MD Prince of Songkla University
  More Information

Responsible Party: Weerawat Kiddee, Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University Hat-yai,, Songkhla, Thailand., Thailand
ClinicalTrials.gov Identifier: NCT01067482     History of Changes
Other Study ID Numbers: EC 52-336-02-1-2
First Submitted: February 10, 2010
First Posted: February 11, 2010
Last Update Posted: March 23, 2010
Last Verified: October 2009

Keywords provided by Prince of Songkla University:
OCT
spectral domain cirrus
glaucoma
glaucoma suspect
normal population

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases